¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

ºÐ´ç¼­¿ï´ëÇб³º´¿ø Á¦6ȸ ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ °æÀÎÁöȸ ½ÉÆ÷Áö¾ö : 2022-10-15

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
ºÐ´ç¼­¿ï´ëÇб³º´¿ø Á¦6ȸ ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ °æÀÎÁöȸ ½ÉÆ÷Áö¾ö : 2022-10-15
±³À°ÀÏÀÚ : 2022-10-15
±³À°Àå¼Ò : ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÇコÄɾîÇõ½ÅÆÄÅ© ¹Ì·¡È¦(4F)  
±³À°ÁÖÁ¦ : Á¦6ȸ ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ °æÀÎÁöȸ ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : °æÀÎÁöȸ  
´ã´çÀÚ : Á¶¿¹¸®
¿¬¶ôó : 02-582-8222  
À̸ÞÀÏ : yehc@kscvi.org      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : °æ±âµµ
±³À°½Ã°£ : 7 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 09:00~09:15 Taming Highly Calcified CTO(Chronic Total Occlusion)  À¯Ã¶¿õ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 09:15~09:23 CTO(Chronic Total Occlusion) with Highly Calcified Lesion  ¹®µ¿±Ô(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 09:23~09:38 Stent Failure after CTO(Chronic Total Occlusion) PCI(Percutaneous Coronary Intervention): Prevention or Treament  ¼­Á¸(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 09:38~09:46 CTO(Chronic Total Occlusion) Case with Poor Collateral and Only Antegrade Approach Available  ¹ÚÇÏ¿í(ºÎõ¼¼Á¾º´¿ø) 
Åä·Ð 10-15 ¹Ì·¡È¦(4F) 09:46~10:00 Discussion  () 
È޽Ġ10-15  10:00~10:05 Break  () 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 10:05~10:20 PCI(Percutaneous Coronary Intervention) and Intravascular Imaging Usefulness in Real World Situation  ½Å»óÈÆ(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 10:20~10:28 Intravascular Imaging Case  ±è¿ëö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 10:28~10:43 PCI(Percutaneous Coronary Intervention) and Intravascular Physiology Usefulness in Real World Situation  À±¸íÈ£(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 10:43~10:51 Intravascular Physiology Case  À念¿ì(°¡ÃµÀÇ´ë) 
Åä·Ð 10-15 ¹Ì·¡È¦(4F) 10:51~11:05 Discussion  () 
È޽Ġ10-15  11:05~11:10 Break  () 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 11:10~11:25 The Benefits of Thin-wall Sheath for DRA(Distal Radial Access)  ÀÌ»ó¿±(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 11:25~11:33 Complex PCI(Percutaneous Coronary Intervention) Using 7-Fr Thin-wall Sheath via the DRA(Distal Radial Access)  ±è³²±Õ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 11:33~11:48 The Benefits of Sheathless Guiding Catheter for the Radial Approach  ±èÂùÁØ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 11:48~11:56 DRA(Distal Radial Access) Using Sheathless Guiding Catheter in the Setting of STEMI(ST-elevation Myocardial Infarction)  ³ëÁö¿õ(¿¬¼¼ÀÇ´ë) 
Åä·Ð 10-15 ¹Ì·¡È¦(4F) 11:56~12:10 Discussion  () 
½Ä»ç 10-15  12:10~13:00 Lunch Break  () 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 13:00~13:20 Achieving Target Blood Pressure with Triple Combination_Dukarb Plus  ÃÖ¼ºÈ¯(ÀÎÇÏÀÇ´ë) 
Åä·Ð 10-15 ¹Ì·¡È¦(4F) 13:20~13:30 Discussion  () 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 13:30~13:50 Review of HOST-EXAM(Harmonizing Optimal Strategy for Treatment of coronary artery diseases-EXtended Antiplatelet Monotherapy): What Is the Best Monotherapy after DAPT(Dual Antiplatelet Therapy)?  ¹ÚÇö¿ì(¼øõÇâÀÇ´ë) 
Åä·Ð 10-15 ¹Ì·¡È¦(4F) 13:50~14:00 Discussion  () 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 14:00~14:15 Topic Review Related to the Complication Case # 1  ¹ÚÇüº¹(°¡Å縯°üµ¿ÀÇ´ë) 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 14:15~14:23 Complication Case # 1: Distal Wire Fragment Fracture during Coronary Intervention  ÀÓä¿Ï(¸íÁöº´¿ø) 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 14:23~14:38 Topic Review Related to the Complicaton Case # 2  ±è±ââ(½ÃÈ­º´¿ø) 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 14:38~14:46 Complicaton Case # 2: Perclose Closure Device Breakage and Embolization during Deployment  ±Ç¼º¿í(ÀÎÁ¦ÀÇ´ë) 
Åä·Ð 10-15 ¹Ì·¡È¦(4F) 14:46~15:00 Discussion  () 
±âŸ 10-15 ¹Ì·¡È¦(4F) 15:00~15:20 °æÀÎÁöȸ ÃÑȸ  () 
È޽Ġ10-15  15:20~15:30 Coffee Break  () 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 15:30~15:45 Preparation and Setup Process of TAVR(Transcatheter Aortic Valve Replacement) for Beginner  ±è¿øÀå(Â÷ÀÇ´ë) 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 15:45~15:53 Interesing TAVR(Transcatheter Aortic Valve Replacement) Case for Beginner  ÃÖ¶ô°æ(ÀÎõ¼¼Á¾º´¿ø) 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 15:53~16:08 Planning EVAR(EndoVascular Aortic Repair) for Challenging Proximal Necks  ÃÖÀÍÁØ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 16:08~16:16 Interesting Case of Endoleak after EVAR(EndoVascular Aortic Repair)  ÀåÁö¿ë(±¹¹Î°Ç°­º¸Çè Àϻ꺴¿ø) 
Åä·Ð 10-15 ¹Ì·¡È¦(4F) 16:16~16:30 Discussion  () 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 16:30~16:45 Provisional Strategy Is Better Even in Left Main Bifurcation Lesion  µµÁØÇü(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 16:45~16:53 My Worst Case after Elective 2-stent Technique  Àå´öÇö(ºÎõ¼¼Á¾º´¿ø) 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 16:53~17:08 Elective 2-stent Technique Is Better in Most Bifurcation Lesion  ÀÌ°æÈÆ(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 10-15 ¹Ì·¡È¦(4F) 17:08~17:16 My Worst Case after Provisional Strategy  ¹Ú°æÀÏ(µ¿¾ÆÀÇ´ë) 
Åä·Ð 10-15 ¹Ì·¡È¦(4F) 17:16~17:30 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ºÐ´ç¼­¿ï´ëÇб³º´¿ø Á¦6ȸ ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ °æÀÎÁöȸ ½ÉÆ÷Áö¾ö : 2022-10-15""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) 2022 Á¦ 3ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°­Á : 2022-10-15
´ÙÀ½±Û Á¦18Â÷ °í¾ç.ÆÄÁÖ.±èÆ÷½ÃÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2022-10-15
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
495 °­¿ø ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø NAFLD(non-alcoholic fatty liver disease) and Cardiometabolic Syndrome [7th Gangwon Heart Seminar 2018] : 2018-09-07 0 920 2018-08-22
494 ÀüºÏ ÀüÁÖ ¿¹¼öº´¿ø ´ëÇÑÀçÈ°ÀÇÇÐȸ È£³²Á¦ÁÖÁöȸ ÀçÈ° ½ÉÆ÷Áö¾ö : 2018-09-07 0 1,040 2018-08-22
493 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø ¾È°ú ±Ý¿äÁý´ãȸ : 2018-09-07 0 850 2018-08-22
492 ¼­¿ï 2018³â °³¿øÀǸ¦ À§ÇÑ °­µ¿°æÈñ´ëÇб³º´¿ø ¼ÒÈ­±âÁúȯ ¿¬¼ö°­Á : 2018-09-06 0 682 2018-08-22
491 Ãæ³² ´Ü±¹´ëÇб³º´¿ø 2018³â Á¦3Â÷ ´ëÇѺ´¸®ÇÐȸ ´ëÀü¤ýÃæûÁöȸ: ÃÖ½ÅÀÇÇÐÁ¤º¸ Ư°­ ¹× º´¸®ÇÐ Áõ·Ê ¹ßÇ¥ : 2018-09-06 0 769 2018-08-22
490 ´ë±¸ ´ëÇѽŻý¾ÆÇÐȸ ´ë±¸°æºÏÁöȸ Áý´ãȸ : 2018-09-06 0 992 2018-08-22
489 Àü³² Á¦257Â÷ ´ëÇѳ»°úÇÐȸ ±¤ÁÖÀü³²Áöȸ Çмú´ëȸ : 2018-09-06 0 573 2018-08-22
488 °æ³² ´ëÇÑÇǺΰúÇÐȸ º£Ã¼Æ®º´ÀÇ ÃÖ½ÅÁö°ß¿¡ °üÇÏ¿© : 2018-09-06 0 717 2018-08-22
487 Ãæ³² °Ç¾ç´ëÇб³º´¿ø ´ëÇÑÇǺΰúÇÐȸ ÃæûÁöºÎÇÐȸ : 2018-09-06 0 897 2018-08-22
486 ´ë±¸ °è¸í´ëÇб³ µ¿»êÀÇ·á¿ø ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ Á¦234Â÷ °æºÏÁöȸ Áý´ãȸ : 2018-09-06 0 740 2018-08-22
485 °æ±â °¡Å縯´ëÇб³ ºÎõ¼º¸ðº´¿ø ´ëÇѺñ´¢±â°úÇÐȸ 2018 Á¦ 3Â÷ ÀÎõ.°æ±âÁöȸ Áý´ãȸ : 2018-09-06 2 1,467 2018-08-22
484 °æ³² ´ëÇÑÈäºÎ¿Ü°úÇÐȸ 2018³âµµ 3Â÷ ºÎ»ê¿ï»ê°æ³² ÈäºÎ¿Ü°ú Áý´ãȸ ¹× °­¿¬ : 2018-09-06 0 695 2018-08-22
483 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø À̺ñÀÎÈÄ°ú 2Çбâ Áö¿ªÀÇ»çÁý´ãȸ : 2018-09-06 0 529 2018-08-22
482 ºÎ»ê ºÎ»ê±¤¿ª½ÃÀÇ»çȸ ¼­±¸ÀÇ»çȸ 9¿ù Çмúȸ : 2018-09-05 0 636 2018-08-22
481 ´ë±¸ 2018³â ´ëÇÑ°¨¿°ÇÐȸ ¿µ³²Áöȸ 9¿ù Áý´ãȸ : 2018-09-05 0 476 2018-08-22
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷